Editas Medicine (EDIT) Total Liabilities (2015 - 2025)

Editas Medicine (EDIT) has 11 years of Total Liabilities data on file, last reported at $159.2 million in Q4 2025.

• On a quarterly basis, Total Liabilities fell 23.19% year-over-year to $159.2 million in Q4 2025; TTM through Dec 2025 was $159.2 million, a 23.19% decrease from a year earlier, with the FY2025 full-year figure at $159.2 million, down 23.19% from the prior year.
• Total Liabilities for Q4 2025 stood at $159.2 million, down from $188.3 million in the prior quarter.
• Over the last five years, Total Liabilities for EDIT reached as high as $207.3 million in Q4 2024 and fell as low as $110.3 million in Q1 2022.
• Historically, Total Liabilities has averaged $150.8 million across 5 years, with a median of $146.3 million in 2023.
• Across the five-year window, Total Liabilities sank 38.71% in 2021 and surged 38.16% in 2024, its largest moves.
• Year by year, Total Liabilities stood at $123.8 million in 2021, then climbed by 24.06% to $153.6 million in 2022, then dropped by 2.33% to $150.1 million in 2023, then jumped by 38.16% to $207.3 million in 2024, then declined by 23.19% to $159.2 million in 2025.
• Per Business Quant data, the three most recent Total Liabilities figures were $159.2 million in Q4 2025, $188.3 million in Q3 2025, and $191.4 million in Q2 2025.